Priya Bisht
Overview
Explore the profile of Priya Bisht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bisht P, Bhattacharya A, Pal A, Singh R, Kumar Verma S
Eur J Med Chem
. 2024 Dec;
283():117160.
PMID: 39708765
The inhibition of enzyme DPP-4 is pivotal for targeting type 2 diabetes mellitus (DM). The study introduces two series of novel 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-diones derivatives (PB01-PB10) and 3,7-dihydro-1H-purine-2,6-diones compounds (PB11-PB16) were developed...
2.
Dhanavath N, Bisht P, Jamadade M, Murti K, Wal P, Kumar N
Mini Rev Med Chem
. 2024 Oct;
PMID: 39444180
Glioblastoma (GBM) is the most prevalent and deadly primary brain tumor. The current treatment for GBM includes adjuvant chemotherapy with temozolomide (TMZ), radiation therapy, and surgical tumor excision. There is...
3.
Beere V, Choudhary K, Bisht P, Rai A, Kumar N
3 Biotech
. 2024 Sep;
14(10):232.
PMID: 39280801
The prevalence of psychological disorders has surged since the 1990s, posing a significant global health burden with depressed individuals averaging six lost hours per week and contributing to over 20%...
4.
Bisht P, Prasad S, Choudhary K, Pandey R, Aishwarya D, Aravind V, et al.
Front Pharmacol
. 2024 Aug;
15:1431085.
PMID: 39148542
Glioblastoma, which affects a large number of patients every year and has an average overall lifespan of around 14.6 months following diagnosis stands out as the most lethal primary invasive...
5.
Bisht P, Gautam P, Bhattacharya A, Singh R, Kumar Verma S
J Biomol Struct Dyn
. 2024 May;
:1-25.
PMID: 38783776
The DPP-4 enzyme degrades incretin hormones GLP-1 and GIP. DPP-4 inhibitors are found effective in the prevention of the degradation of incretins. Xanthine scaffold-bearing molecules are reported as potential DPP-4...
6.
Sharma R, Bisht P, Kesharwani A, Murti K, Kumar N
Eur J Pharmacol
. 2024 May;
975:176641.
PMID: 38754537
Parkinson's Disease (PD) is a progressive neurodegenerative disorder expected to increase by over 50% by 2030 due to increasing life expectancy. The disease's hallmarks include slow movement, tremors, and postural...
7.
Jitte S, Keluth S, Bisht P, Wal P, Singh S, Murti K, et al.
CNS Neurol Disord Drug Targets
. 2024 May;
23(12):1425-1449.
PMID: 38747226
Depression is among the main causes of disability, and its protracted manifestations could make it even harder to treat metabolic diseases. Obesity is linked to episodes of depression, which is...
8.
Bisht P, Singh B, Sharma P, Lotani N, Negi C, Bhatt I
Int J Med Mushrooms
. 2024 Feb;
26(1):67-78.
PMID: 38305263
This study presents a comprehensive analysis of the methanolic extracts of nine species of wild edible mushrooms (WEM) native to the Darma Valley in the Kumaun Himalaya region. The investigation...
9.
Pandey R, Bisht P, Wal P, Murti K, Ravichandiran V, Kumar N
Mini Rev Med Chem
. 2024 Jan;
24(14):1334-1352.
PMID: 38275029
Background: Uncontrolled cell growth and proliferation, which originate from lung tissue often lead to lung carcinoma and are more likely due to smoking as well as inhaled environmental toxins. It...
10.
Kohal R, Bisht P, Gupta G, Kumar Verma S
Bioorg Chem
. 2024 Jan;
143:107095.
PMID: 38211548
Cancer is indeed considered a hazardous and potentially life-threatening disorder. The JAK/STAT pathway is an important intracellular signaling cascade essential for many physiological functions, such as immune response, cell proliferation,...